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ynamic attachment of microtubules to kineto-
chores during mitosis generates pulling force, or
tension, required for the high ﬁdelity of chromo-
some separation. A lack of tension activates the spindle
checkpoint and delays the anaphase onset. A key step in
the tension–response pathway involves the phosphoryla-
tion of the 3F3/2 epitope by an unknown kinase on un-
tensed kinetochores. Using a rephosphorylation assay in
 
Xenopus
 
 
 
laevis
 
 extracts, we identiﬁed the kinetochore-
associated Polo-like kinase Plx1 as the kinase both neces-
sary and sufﬁcient for this phosphorylation. Indeed, Plx1
D
 
is the physiological 3F3/2 kinase involved in checkpoint
response, as immunodepletion of Plx1 from checkpoint
extracts abolished the 3F3/2 signal and blocked associa-
tion of xMad2, xBubR1, xNdc80, and xNuf2 with kineto-
chores. Interestingly, the kinetochore localization of Plx1
is under the control of the checkpoint protein xMps1, as
immunodepletion of xMps1 prevents binding of Plx1 to
kinetochores. Thus, Plx1 couples the tension signal to
cellular responses through phosphorylating the 3F3/2
epitope and targeting structural and checkpoint proteins
to kinetochores.
 
Introduction
 
Accurate segregation of sister chromatids, which is essential for
cell proliferation, is mediated by the attachment of microtubules
to kinetochores during mitosis. This dynamic attachment gener-
ates pulling forces, or tension, across sister kinetochores to align
chromosomes to the metaphase plate. Tension, in turn, stabilizes
microtubule binding to kinetochores and is an indicator for func-
tional attachment. A lack of tension on kinetochores activates a
surveillance mechanism, the spindle checkpoint, which delays
the onset of anaphase until all kinetochores are under tension
and all chromosomes are properly aligned at the metaphase plate
(Shah and Cleveland, 2000). The checkpoint signal originates
from and is amplified and transduced at kinetochores. It then
leaves kinetochores and diffuses into the cytosol to inhibit the
anaphase-promoting complex/cyclosome (APC/C), which is a
ubiquitin ligase whose activation is required for the separation of
sister chromatids and exit from mitosis. In addition to arresting
the cell cycle progression, components in the tension–response
pathway are likely to contribute to the attachment of microtu-
bules to kinetochores and to the establishment of tension.
Several spindle checkpoint proteins have been character-
ized in vertebrate cells. These include four kinases, Mps1,
Bub1, BubR1, and Aurora B, as well as three additional check-
point proteins, Mad1, Mad2, and Bub3 (for reviews see Mill-
band et al., 2002; Musacchio and Hardwick, 2002; Lens and
Medema, 2003; Taylor et al., 2004). Upon activation of the
checkpoint, Mad2 and BubR1 synergistically bind to Cdc20, an
activator of APC/C, and thereby prevent premature activation
of APC/C and anaphase onset (Sudakin et al., 2001; Tang et al.,
2001; Fang, 2002). The biochemical pathway upstream from
Mad2 and BubR1 remains poorly understood.
Key steps in the response to a lack of tension involve pro-
tein phosphorylation on kinetochores. Indeed, unattached or
untensed kinetochores are hyperphosphorylated (Gorbsky and
Ricketts, 1993; Nicklas et al., 1998) and all four checkpoint ki-
nases are localized to these kinetochores (for reviews see Lens
and Medema, 2003; Taylor et al., 2004). A phosphorylation
step crucial to responses to a lack of tension across sister kinet-
ochores is revealed by the 3F3/2 antibody, a monoclonal anti-
body (Cyert et al., 1988) that recognizes a phosphoepitope of a
yet unidentified protein. Studies in mammalian culture cells
indicate that the presence of the 3F3/2 phosphoepitope at ki-
netochores tightly correlates with the absence of tension in
prophase/prometaphase cells and in cells treated with taxol,
which stabilizes microtubules and abolishes the tension across
sister kinetochores (Gorbsky and Ricketts, 1993; Nicklas et al.,
1995, 1998). Once sister kinetochores achieve tension through
bipolar attachment at metaphase, the 3F3/2 epitope is dephos-
phorylated and the 3F3/2 signal is substantially reduced and
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eventually disappears at the onset of anaphase, suggesting that
the 3F3/2 epitope responds to tension (Nicklas et al., 1995).
Microinjection of the 3F3/2 antibody into mitotic cells pre-
serves the 3F3/2 epitope and prolongs the checkpoint arrest,
suggesting a role of the 3F3/2 phosphorylation in checkpoint
arrest in mammalian cells (Campbell and Gorbsky, 1995). It
has been postulated that the 3F3/2 kinase and its substrate are
tension-sensitive components of the spindle checkpoint (Nick-
las et al., 1995, 1998). At the molecular level, the 3F3/2
epitope and the kinase remain to be identified, although in
vitro rephosphorylation assay suggests that the kinase is asso-
ciated with the kinetochores (Nicklas et al., 1998; Campbell et
al., 2000). Given the important role of tension in controlling
the fidelity of chromosome separation, it is critical to deter-
mine the molecular identity of the 3F3/2 antigen and the 3F3/2
kinase and to investigate the mechanism of their response to a
lack of tension.
Multiple kinases are localized to mitotic kinetochores.
In addition to the four checkpoint kinases, Polo-like kinase
(Plk1) is also associated with kinetochores in prometaphase
and metaphase cells. Plk1 is a key mitotic kinase that controls
centrosome maturation, mitotic entry, bipolar spindle assem-
bly, sister chromatid cohesion/separation, and cytokinesis
(for review see Barr et al., 2004). The diverse function of
Plk1 in mitosis makes its activity at kinetochores difficult to
investigate. Plk1 has been reported to be required for spindle
assembly, and a reduction of the Plk1 protein level by RNA
interference (RNAi) in human cells activates the spindle
checkpoint as a result of defects in the mitotic spindle (Su-
mara et al., 2004; van Vugt et al., 2004), suggesting a lack of
requirement of Plk1 in the checkpoint arrest. However, this
conclusion is complicated by a possibility that the residual
Plk1 protein in knockdown cells, although not adequate for
spindle assembly, may be sufficient to carry out its function
at kinetochores.
To understand the tension-sensitive response, we set
out to investigate the biochemical mechanism for phosphor-
ylation of the 3F3/2 epitope at kinetochores and report here
the identification of the 3F3/2 kinase. To avoid pleiotrophic
effects of mitotic kinases in living cells, we used a 
 
Xenopus
laevis 
 
cell-free system to investigate the tension-sensitive
phosphorylation. Among the six kinetochore-associated ki-
nases tested, only the 
 
X. laevis 
 
Plk1 homologue, Plx1, is
both necessary and sufficient for phosphorylation of the
3F3/2 epitope at kinetochores. Immunodepletion of Plx1
abolished the 3F3/2 signals at kinetochores and substantially
reduced the amounts of xMad2, xBubR1, xNdc80, and
xNuf2 localized to kinetochores. Interestingly, localization
of Plx1 to kinetochores requires the checkpoint protein
xMps1, indicating that Plx1 itself is under the control of the
spindle checkpoint. We propose that Plx1 is involved in the
tension-sensitive response by phosphorylating the 3F3/2
epitope and targeting structural and checkpoint proteins to
kinetochores. The function of Plx1 as the 3F3/2 kinase is
conserved during evolution, as knockdown of human Plk1
also abolished the kinetochore-associated 3F3/2 epitope in
HeLa cells.
Figure 1. The 3F3/2 epitope in X. laevis is a phosphospecific kinetochore
antigen. (A) Asynchronous XTC cells in mitosis (M) and in interphase (I)
were stained with the 3F3/2 antibody and with an anti–xCenp-A anti-
body. The majority of the xCenp-A dots in M cells contained the 3F3/2
signals, although a few lacked the 3F3/2 staining, likely because of the
dephosphorylation that occurred during sample processing. (B and C)
XTC cells arrested with taxol or released from taxol arrest were stained for
the 3F3/2 antigen and for xCenp-A or xBub1. Insets show a magnified
image of the boxed areas. (D) Nuclei purified from checkpoint extracts
(top) were dephosphorylated with  -phosphatase (middle) and then re-
phosphorylated with ATP (bottom). (A–D) Red, 3F3/2; green, xCenp-A or
xBub1. Arrowheads and arrow point to the 3F3/2 signals on centrosomes
and at the midbody, respectively. Bars, 5  m. 
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3F3/2 antibody recognizes unattached kinetochores that are
not under tension, a finding that is consistent with previous
reports in mammalian cells (Gorbsky and Ricketts, 1993;
Nicklas et al., 1995).
We then determined the localization of the 3F3/2 anti-
gen in 
 
X. laevis
 
 checkpoint extracts. Nuclei were purified
from 
 
X. laevis 
 
checkpoint extracts onto the coverslip by cen-
trifugation, fixed, and then stained with the 3F3/2 antibody.
The 3F3/2 epitope colocalized with xBub1 (Fig. 1 D). To deter-
mine whether the 3F3/2 epitope corresponds to a phospho-
epitope, purified nuclei on coverslips were incubated with
 
 
 
-phosphatase. Phosphatase treatment had no effect on the lo-
calization of xBub1, but it removed the 3F3/2 epitope from
kinetochores (Fig. 1 D). To determine whether the 3F3/2 ki-
nase is associated with kinetochores, nuclei purified from
checkpoint extracts were first treated with 
 
 
 
-phosphatase and
then rephosphorylated by the addition of ATP. Interestingly,
the 3F3/2 epitope was regenerated in the presence of ATP
(Fig. 1 D). Thus, the 3F3/2 kinase in 
 
X. laevis 
 
extracts is lo-
calized at kinetochores in proximity to its substrate, which is
consistent with a previous paper in a mammalian system
(Campbell et al., 2000).
 
Results
 
The 
 
X. laevis 
 
3F3/2 epitope is a 
phosphospecific kinetochore antigen
 
To investigate the biochemistry of the 3F3/2 pathway, we an-
alyzed the 3F3/2 epitope in 
 
X. laevis 
 
cells and extracts. Asyn-
chronous 
 
X. laevis 
 
tissue culture (XTC) cells were costained
with a 3F3/2 antibody and an antibody against xCenp-A,
which is a structural component of kinetochores. The 3F3/2
epitope was present only in mitotic cells, but not in inter-
phase cells (Fig. 1 A). In addition to centrosomal staining,
the 3F3/2 epitope colocalized with xCenp-A in mitotic cells,
indicating that the 3F3/2 antibody recognizes a mitotic kinet-
ochore epitope (Fig. 1 A). To determine the sensitivity of the
3F3/2 epitope to tension across sister kinetochores, XTC
cells were treated with taxol. In early prometaphase cells
treated with taxol, strong 3F3/2 signals colocalized with
xCenp-A and xBub1, which is a kinetochore-associated
checkpoint protein (Fig. 1, B and C). As cells were released
from taxol arrest, both the 3F3/2 epitope and xBub1 were di-
minished from kinetochores, whereas xCenp-A remained at
kinetochores (Fig. 1, B and C). Thus, in 
 
X. laevis 
 
cells, the
Figure 2. Plx1 is both necessary and suffi-
cient to phosphorylate the 3F3/2 epitope at
kinetochores. (A) Nuclei purified from check-
point extracts carrying the 3F3/2 epitope (left)
were dephosphorylated, treated with NEM,
and rephosphorylated with either ATP (middle)
or ATP plus CSF extract (right). Nuclei were
then stained for the 3F3/2 epitope and
xBub1. (B) Immunodepletion of kinetochore-
associated kinases from CSF extracts. CSF ex-
tracts were depleted of xMps1 (lane 1),
xBub1 (lane 4), xBubR1 (lane 8), and Plx1
(lane 11). 1  l of depleted extracts and mock-
depleted extracts (lanes 2, 5, 9, and 12) and
0.05  l of input extracts (lanes 3, 6, 7, and
10) were analyzed by Western blotting to de-
termine the depletion efficiency. xMad1 and
xMad2 were shown here to demonstrate the
specificity of the immunodepletion. (C and D)
Rephosphorylation of 3F3/2 by extracts de-
pleted of kinetochore-associated kinases.
Nuclei were prepared as in A and rephos-
phorylated with either ATP (first column in C)
or ATP plus depleted extracts prepared in B.
ID, immunodepletion. (E) Mean kinetochore
fluorescence intensity of xBub1 (green) and
3F3/2 (red) signals from samples rephosphor-
ylated with xBubR1- or Plx1-depleted extracts.
The fluorescence intensity was normalized to
the corresponding values derived from mock-
depleted extracts. Error bars represent SD. (F)
Nuclei from checkpoint extracts were dephos-
phorylated and rephosphorylated with ATP or
with ATP plus recombinant His6-Plx1. (A, C, D,
and F) Red, 3F3/2; green, xBub1. Bars, 5  m. 
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Plx1 is both necessary and sufficient to 
phosphorylate the 3F3/2 epitope at 
kinetochores
 
We used a candidate approach to identify the 3F3/2 kinase.
Six  kinetochore-associated mitotic kinases—xMps1, xBub1,
xBubR1, xAurora B, Plx1, and Cdc2/cyclin B (for reviews see
Lens and Medema, 2003; Taylor et al., 2004)—were tested. To
assay for the 3F3/2 kinase activity, we modified a rephosphory-
lation assay developed in mammalian cells (Nicklas et al.,
1995). Nuclei purified from 
 
X. laevis
 
 checkpoint extracts were
treated first with 
 
 
 
-phosphatase to remove the phosphoepitope
and then with 
 
N
 
-ethyl maleimide (NEM), a sulfhydryl alkylat-
ing agent that covalently modifies cysteine residues, to inacti-
vate kinetochore-associated kinases. The resulting nuclei were
used as substrates in an in vitro kinase assay. Addition of ATP
alone did not recover the 3F3/2 signals, whereas ATP plus 
 
X.
laevis
 
 meiotic metaphase extracts (cytostatic factor [CSF] ex-
tracts) regenerated the 3F3/2 epitope (Fig. 2 A), indicating that
CSF extracts contain the 3F3/2 kinase.
We then examined the three known spindle checkpoint
kinases—xMps1, xBub1, and xBubR1—for their ability to
generate the 3F3/2 epitope. Checkpoint kinases were individu-
ally immunodepleted from CSF extracts with respective anti-
bodies to an extent that was 
 
 
 
95% (Fig. 2 B). Surprisingly, the
depleted extracts retained the ability to rephosphorylate the
3F3/2 epitope (Fig. 2 C). For example, a quantitative analysis
indicated that xBubR1- and mock-depleted extracts had com-
parable mean levels of 3F3/2 fluorescence intensity at kineto-
chores (Fig. 2 E). Thus, none of these three checkpoint kinases
is the 3F3/2 kinase.
Next, we analyzed the kinetochore kinase Plx1. Plx1-
depleted extracts lost the ability to rephosphorylate the 3F3/2
epitope (Fig. 2 D). An analysis of the mean 3F3/2 fluorescence
intensity at kinetochores indicated that the intensity from Plx1-
depleted extracts was only 6% of that from control-depleted
extracts (Fig. 2 E). As a control, we found no significant differ-
ence in the xBub1 intensity between nuclei treated with Plx1-
versus control-depleted extracts (Fig. 2 E). To rule out the pos-
sibility that the lack of phosphorylation is attributable to the
coprecipitation of a kinase associated with Plx1, purified re-
combinant His
 
6
 
-Plx1 was used in the rephosphorylation assay.
Recombinant Plx1 was sufficient to regenerate the 3F3/2 phos-
phoepitope (Fig. 2 F), whereas the active recombinant GST-
xAurora B and the active Cdc2/cyclin B kinase failed to restore
any 3F3/2 signal (not depicted). Together, these results show
that Plx1 is both necessary and sufficient to phosphorylate the
3F3/2 epitope at kinetochores.
 
Plx1 is the physiological kinase for the 
3F3/2 epitope
 
If Plx1 is indeed the 3F3/2 kinase, immunodepletion of Plx1
should abolish the 3F3/2 epitope on kinetochores in spindle
checkpoint extracts. To test this prediction, we immunodepleted
Plx1 from CSF extracts to 
 
 
 
99.5%, and then assembled the
checkpoint extracts by adding sperm nuclei and nocodazole (Fig.
3 A). Immunodepletion of Plx1 abolished its kinetochore stain-
ing (Fig. 3 B), indicating that Plx1 is indeed a kinetochore pro-
tein in 
 
X. laevis
 
 extracts. Upon depletion of Plx1, the 3F3/2
epitope was also absent from kinetochores, whereas the localiza-
tion of xCenp-A was not affected (Fig. 3 B). To rescue the Plx1-
depletion phenotype, we translated recombinant Plx1, using in
vitro–transcribed Plx1 mRNA, in 
 
X. laevis
 
 CSF extracts that had
been depleted of endogenous Plx1 to 
 
 
 
99.5%. Addition of
translated Plx1 to the depleted extracts at only 
 
 
 
5% of the en-
dogenous Plx1 level efficiently restored both the Plx1 and 3F3/2
signals at kinetochores. In contrast, addition of an in vitro–
translated Plx1 kinase-dead mutant (Plx1-KD) failed to restore
the 3F3/2 signals, despite the fact that Plx1-KD was efficiently
targeted to kinetochores (Fig. 3 B). A quantitative analysis of
3F3/2 kinetochore fluorescence intensity in these samples further
supported the requirement of the Plx1 kinase activity for phos-
phorylating the 3F3/2 epitope (Fig. 3 C). Together, our data
(Figs. 2 and 3) indicate that Plx1 is the physiological kinase for
the 3F3/2 epitope in checkpoint extracts. We found that Plx1 has
an extremely high affinity for kinetochores, as immunodepletion
of Plx1 by 99% affected neither its localization at kinetochores
nor the phosphorylation of the 3F3/2 epitope in checkpoint ex-
tracts (not depicted). This high affinity of Plx1 to kinetochores
also explains why the addition of only 5% of wild-type Plx1 to
the depleted extracts is sufficient to rescue the 3F3/2 signal.
Therefore, all the depletion experiments in this paper were per-
formed with a depletion efficiency of 
 
 
 
99.5% for Plx1.
 
Plx1 targets xBubR1 and xMad2 to 
kinetochores
 
We next investigated the function of Plx1 in checkpoint re-
sponse. The fact that Plx1 is required for a calcium-triggered
exit from the CSF arrest (Descombes and Nigg, 1998) pre-
cludes the use of conventional checkpoint assays, such as DNA
morphology, H1 kinase activity, and cyclin B stability, to as-
sess the status of the spindle checkpoint in Plx1-depleted ex-
tracts. Taking an alternative approach, we examined whether
the localization of the checkpoint proteins is dependent on
Plx1. We reasoned that if Plx1 is involved in checkpoint con-
trol, it may act to control the localization of checkpoint proteins
at kinetochores. To test this prediction, we focused on xMad2
and xBubR1, two essential kinetochore-associated checkpoint
proteins required for the inhibition of APC/C (Sudakin et al.,
2001; Tang et al., 2001; Fang, 2002).
In nuclei prepared from Plx1-depleted extracts (
 
n
 
 
 
 
 
 117),
the fluorescence intensity of xMad2 at kinetochores fell into
three groups. The first group of nuclei, which corresponded to
53% of nuclei, had no detectable xMad2 staining on kineto-
chores (Fig. 3 D, second column). The second group of nuclei,
which corresponded to 39% of nuclei, contained only weak sig-
nals on kinetochores (
 
 
 
25% of the intensity found in mock-
depleted samples; Fig. 3 D, third column). The third group of
nuclei, which corresponded to 8% of the nuclei, had strong
xMad2 staining with intensity resembling that of mock-
depleted samples (Fig. 3 D, compare first and fourth columns).
In contrast, the majority (92%, 
 
n
 
 
 
 
 
 107) of nuclei from mock-
depleted extracts had strong xMad2 staining (Fig. 3 D, first
column), whereas only 6 and 2% of nuclei had weak and no
xMad2 staining, respectively (not depicted). 
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Upon addition of translated wild-type Plx1 to the Plx1-
depleted extracts, the phenotype reverted back to that of the
mock-depleted samples, with 94 and 6% of nuclei (
 
n
 
 
 
 
 
 116)
showing strong and weak xMad2 signals on kinetochores, re-
spectively (Fig. 3 E). The ability of the exogenously added
Plx1 to rescue the defect in xMad2 localization requires the
kinase activity, as the addition of Plx1-KD did not rescue the
defect in xMad2 localization, although Plx1-KD itself was ef-
ficiently targeted to kinetochores. In the Plx1-KD add-back
extracts, 35, 51, and 14% of nuclei (
 
n
 
 
 
 
 
 120) had no, weak,
and strong xMad2 kinetochore signals, respectively, numbers
comparable to those observed in Plx1-depleted extracts (Fig. 3,
D and E).
Similarly, depletion of Plx1 reduced the amount of
xBubR1 recruited to kinetochores (Fig. 3 F, compare second
and third columns with first column). A quantitative analysis
of xBubR1 fluorescence intensity indicated that depletion of
Plx1 reduced, on average, 
 
 
 
70% of xBubR1 signals on ran-
domly selected kinetochores (Fig. 3 C). In addition, no BubR1
signal was detectable in a small number (5%) of nuclei from
depleted extracts (Fig. 3 E, third column). The addition of
translated wild-type Plx1, but not Plx1-KD, rescued the defect
in kinetochore localization of xBubR1 (Fig. 3, C and F). The
lack of kinetochore localization for xBubR1 and xMad2 was
not attributable to codepletion of these two proteins with Plx1,
as the levels of both proteins were not affected by immunode-
pletion (Fig. 3 A). We conclude that the Plx1 kinase activity is
required to target xMad2 and xBubR1 to kinetochores. Our
observation is consistent with the previous finding that phos-
phorylation of kinetochore components is required for the
binding of Mad2 to kinetochores in mammalian cells (Waters
et al., 1999). Similarly, it has been reported that localization of
Figure 3. Plx1 is the physiological 3F3/2
kinase.  (A) Extracts were mock depleted
(lane 6) or depleted of Plx1 (lanes 3–5). Plx1
(lane 4) or Plx1-KD (lane 5) was translated in
CSF extracts that had been depleted of endog-
enous Plx1 and then added to the Plx1-depleted
extracts. Lanes 1 and 2 show input extracts.
The volumes of extracts loaded were as indi-
cated. Different amounts of input extracts were
loaded to quantify the degree of depletion
and add-back. (B and D–F) 3F3/2, Plx1,
xCenp-A, xMad2, and xBubR1 staining of nu-
clei purified from checkpoint extracts that had
undergone immunodepletion (ID) and add-back
(AB) of the indicated proteins. Red, 3F3/2;
green, Plx1, xCenp-A, xMad2, and xBubR1.
(C) Mean kinetochore fluorescence intensity
(from 15 randomly selected kinetochores) of
xBubR1 (green) and 3F3/2 (red) signals from
samples that were depleted of Plx1 and then
added back with the indicated proteins. The
fluorescence intensity was normalized to the
corresponding values derived from mock-
depleted extracts. Error bars represent SD.
Bars, 5  m. 
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BubR1 is dependent on phosphorylation of kinetochore com-
ponents in 
 
Drosophila
 
 
 
melanogaster
 
 S2 cells (Logarinho et
al., 2004).
 
Generation of the 3F3/2 epitope depends 
on Plk1 in HeLa cells
 
To address whether the relationship between Plx1 and the 3F3/2
epitope is conserved during evolution, we tested the role of
Plk1 in phosphorylation of the 3F3/2 epitope in HeLa cells. We
transfected small interfering RNAs (siRNAs) into synchro-
nized HeLa cells to achieve the maximal knockdown and ana-
lyzed the immediate phenotype during the first mitosis after
transfection (Fig. 4 A). Western blot analysis indicated that the
level of Plk1 was efficiently reduced through RNAi by 95%
(Fig. 4 A). The reduction of Plk1 is also drastic on kinetochores
at the cellular level. Whereas 100% of prometaphase cells (
 
n
 
 
 
 
 
56) in the control-transfected sample had strong Plk1 signals
on kinetochores, 89.9% of prometaphase cells (
 
n
 
 
 
 
 
 148) in the
Plk1 knockdown sample had no detectable Plk1 signal on ki-
netochores (Fig. 4 B). The remaining 10.1% of cells had weak
but visible Plk1 signals on kinetochores. To quantify the level
of Plk1 knockdown on individual kinetochores, cells were co-
stained with Crest serum and Plk1. Crest serum recognizes
structural components at inner centromeres not affected by
Plk1 knockdown (Fig. 4 B) and was used here as an internal
reference to normalize the Plk1 fluorescence intensity. Upon
knockdown of Plk1, the normalized fluorescence intensity of
Plk1 signals at prometaphase kinetochores was reduced to
 
 
 
7.3% of that of control cells (Fig. 4, B and C). We next
examined the level of the kinetochore 3F3/2 epitope in
prometaphase cells in which Plk1 was not detectable on kineto-
chores. Prometaphase cells in control knockdown cells con-
tained strong 3F3/2 signals at kinetochores (Fig. 4, D and E). In
agreement with our results from extract experiments, the 3F3/2
signals were absent in Plk1 knockdown cells (Fig. 4, C and D).
To exclude the possibility that Plk1 is generally required for
Figure 4. Plk1 is required for the generation of the
3F3/2 epitope in HeLa cells. (A, top) Schematic of
double-thymidine synchronization and siRNA trans-
fection of HeLa cells. (bottom) Western blot analysis
of Plk1 and control knockdown cell lysates to deter-
mine the knockdown efficiency. p38 MAPK was used
as a loading control. The volumes of HeLa cell lysates
loaded were as indicated. Different amounts of cell ly-
sates were loaded from the control knockdown sam-
ple to quantify the degree of Plk1 knockdown. (B and
D–G) Plk1 or control knockdown cells were fixed at
11 h after release from the second thymindine arrest.
Prometaphase cells were stained with the following
antibodies: (B) Crest serum (red) and anti-Plk1 (green);
(D) 3F3/2 antibody (red) and anti-Plk1 (green); (E)
3F3/2 antibody (red), Crest serum (green), and anti-
Plk1 (green); (F) Plk1 (red) and Mad2 (green); (G)
Plk1 (red) and BubR1 (green). In D, F, and G, arrow-
heads point to 3F3/2 and Plk1 signals at spindle
poles. Bars, 5  m. (C) Mean kinetochore fluores-
cence intensity (from randomly selected kinetochores
of multiple prometaphase cells) of Plk1, 3F3/2,
Mad2, and BubR1 signals from Plk1 (green) or con-
trol knockdown (red) cells. The fluorescence intensity
was normalized to the corresponding values derived
from control knockdown cells. Error bars represent SD.
(H) HeLa cells were synchronized by double-thymidine
arrest/release and transfected with siRNAs as de-
scribed in A, except that transfected cells were re-
leased from the second thymidine arrest in either the
presence (  Noc) or absence (  Noc) of 100 ng/ml
nocodazole. At 14 h after release from the second
thymidine arrest, cells were fixed, and the mitotic in-
dex was counted (n   150 cells for each sample). 
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the assembly of mitotic kinetochores, but not specifically in-
volved in the phosphorylation of the 3F3/2 epitope, we triple
stained the Plk1 knockdown cells with 3F3/2, Plk1, and Crest
serum. Cells with efficient knockdown of Plk1 were identified
by the absence of Plk1 signals at the spindle poles. In these
cells, the 3F3/2 epitope was absent, but the Crest signals per-
sisted, indicating that knockdown of Plk1 does not affect the
integrity of the inner centromere structure (Fig. 4 E). Thus,
Plk1 is also required for the formation of the 3F3/2 phosphoe-
pitope in mammalian cells, suggesting a common mechanism
for tension sensing/response from 
 
X. laevis
 
 to human.
 
Plk1 contributes to the loading of Mad2 
onto kinetochores in HeLa cells
 
We next investigated whether Plk1 controls the kinetochore lo-
calization of the spindle checkpoint proteins Mad2 and BubR1
in HeLa cells. In prometaphase cells with undetectable Plk1
signals, the level of Mad2 at the kinetochores was reduced to
 
 
 
50% of that of control cells (Fig. 4, C and F), suggesting that,
under our experimental conditions, Plk1 contributes to but is
not required for the loading of Mad2 to kinetochores in HeLa
cells. In contrast, the kinetochore BubR1 level was not affected
in Plk1 knockdown cells (Fig. 4, C and G), indicating a lack of
requirement for Plk1. These data raise the possibility that dif-
ferences may exist in the kinetochore assembly pathway and in
the spindle checkpoint signaling pathway between 
 
X. laevis
 
extracts and mammalian cells.
We next examined the role of Plk1 in the checkpoint ar-
rest. Upon release from the second thymidine arrest, control-
transfected cells peaked in mitosis between 10 and 12 h after
release (unpublished data). At 14 h after release, nearly all of
the control-transfected cells had exited mitosis, whereas 
 
 
 
50%
of the Plk1 knockdown cells remained at prometaphase (Fig. 4
H and not depicted), indicating a mitotic arrest in Plk1 knock-
down cells. In the presence of nocodazole, the mitotic index of
control-transfected cells became comparable to that of Plk1
knockdown cells (0.51 and 0.46, respectively; Fig. 4 H), indi-
cating the activation of the spindle checkpoint in both samples.
These observations are consistent with those of previous stud-
ies showing that Plk1 is not required for checkpoint arrest in
mammalian cells (Sumara et al., 2004; van Vugt et al., 2004).
Instead, knockdown of Plk1 activates spindle checkpoint because
of defects in spindle structure.
 
Localization of Plx1 to kinetochores is 
controlled by the checkpoint protein 
xMps1
 
We next asked whether Plx1 itself is also under the control of
upstream checkpoint components, such as xMps1. xMps1 was
depleted from CSF extracts before the assembly of the check-
point extracts, and the kinetochore localization of Plx1 was
examined in the depleted checkpoint extracts. Interestingly,
depletion of xMps1 completely abolished the Plx1 signal at ki-
netochores without affecting the level of the Plx1 protein in
extracts (Fig. 5, A and B). Addition of in vitro–translated
wild-type xMps1, but not the xMps1 kinase-dead mutant
(xMps1-KD), rescued the kinetochore localization of Plx1
(Fig. 5 A). In all cases, xCenp-A localization was not affected,
indicating that depletion of xMps1 did not affect the structural
integrity of inner centromeres. We conclude that the check-
point kinase xMps1 is required to recruit Plx1 to kinetochores.
 
xMps1 and xPlx1 control the outer 
kinetochore structure
 
To determine whether xMps1 and Plx1 control the outer kinet-
ochore structure, nuclei from xMps1- or Plx1-depleted extracts
were stained with xNdc80 and xNuf2. xNdc80 and xNuf2 form
a complex required for microtubule attachment to kinetochores
(DeLuca et al., 2002). Depletion of xMps1 completely re-
moved xNdc80 and xNuf2 from the kinetochores, and their ki-
netochore localization can only be rescued by the addition of
wild-type xMps1 but not xMps1-KD (Fig. 6 A). Similarly, Plx1
is also required for the kinetochore localization of xNdc80 and
xNuf2 (Fig. 6 B). Interestingly, addition of either wild type or
Plx1-KD was sufficient to rescue the kinetochore localization
Figure 5. xMps1 controls the kinetochore localization of Plx1. (A) CSF
extracts were either mock depleted or depleted of xMps1 and then added
back with the indicated proteins. Nuclei were purified from depleted
checkpoint extracts and stained for xMps1, Plx1, and xCenp-A. ID, immu-
nodepletion; AB, add-back. Bar, 5  m. (B) Depletion efficiency was deter-
mined by Western blot analysis of equal volumes of mock- (lane 1) or
xMps1-depleted (lane 2) extracts as well as xMps1-depleted extracts with
the add-back of xMps1 (lane 3) or xMps1-KD (lane 4). 
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of xNdc80 and xNuf2, indicating a kinase-independent func-
tion of Plx1 at kinetochores, although we cannot exclude
the possibility that the residual endogenous Plx1, even with
 
 
 
99.5% depletion, acted together with Plx1-KD to mediate the
rescue. Together, our data suggest that both xMps1 and Plx1
control the assembly of the outer kinetochore structure.
 
Discussion
 
A lack of tension across sister kinetochores activates down-
stream cellular responses, including the spindle checkpoint,
which delays the onset of anaphase and thereby ensures the
fidelity of chromosome separation. A key cellular component
that couples the tension sensor to downstream responses is the
3F3/2 epitope, whose phosphorylation is triggered by the lack
of tension. We have shown here that the Polo-like kinase Plx1
is both necessary and sufficient for phosphorylation of the 3F3/2
epitope in vitro and is the physiological 3F3/2 kinase in vivo.
Thus, Plx1 has a direct role in the cellular responses to the lack
of tension, and possibly in the spindle checkpoint control. Con-
sistent with this, our results show that Plx1 is localized to kinet-
ochores and that this localization is under the control of xMps1,
a checkpoint kinase required for tension-sensitive cell cycle ar-
rest (Dorer et al., 2005). Furthermore, Plx1 targets the check-
point proteins xMad2 and xBubR1 as well as structural pro-
teins xNdc80 and xNuf2 to kinetochores, further linking Plx1
to checkpoint responses in 
 
X. laevis
 
 extracts.
What is the physiological role of Plx1 in spindle check-
point control? Cellular responses to checkpoint activation
usually consist of two branches, one targeting the cell cycle
machinery to halt the cell cycle progression and the other tar-
geting the repair mechanism to fix cellular defects, leading to
inactivation of the checkpoint. Indeed, emerging evidence sug-
gests that components in the spindle checkpoint pathway are
bifunctional and act in both branches. For example, the check-
point kinases Mps1, Bub1, BubR1, and Aurora B are not only
involved in kinetochore-mediated signaling to inhibit APC/C
but also control spindle assembly, attachment of microtubules
to kinetochores, and biorientation of sister chromatids (Tanaka
et al., 2002; Lampson et al., 2004; Jones et al., 2005; Lampson
and Kapoor, 2005; Meraldi and Sorger, 2005). Similarly, the
checkpoint protein Mad2 not only functions as an inhibitor of
APC/C to prevent premature anaphase onset but also contrib-
utes to the biorientation of homologous chromosomes during
meiosis (Shonn et al., 2003). Consistent with a role of Plk1 in
response to the lack of tension, it has been reported that Plk1
promotes the formation of the bipolar spindle and is required
for the generation of tension across sister kinetochores in mam-
malian cells (Sumara et al., 2004; van Vugt et al., 2004). We
report here that Plk1/Plx1 is the kinase that phosphorylates the
3F3/2 epitope in the absence of tension and propose that one
function of the tension-sensitive pathway is to promote tension
across sister kinetochores through the action of the Plk1/Plx1
kinase. In agreement with this model, our data reveal that Plx1
is required for the assembly of the xNdc80–xNuf2 complex
onto kinetochores in 
 
X. laevis
 
 extracts, indicating that Plx1
controls certain aspects of the outer kinetochore structure. Be-
cause this complex mediates the attachment of microtubules to
kinetochores (DeLuca et al., 2002), Plx1, through the loading
of the xNdc80–xNuf2 complex, may act to promote the binding
of microtubules to kinetochores and the establishment of ten-
sion across sister kinetochores. The presence of tension then
stabilizes microtubule attachment and changes the dynamics of
checkpoint proteins on kinetochores, leading to the inactivation
of the checkpoint pathway (Howell et al., 2000, 2004; Shah et
al., 2004). This model predicts that Plk1 is a key mediator in
the tension–response pathway and that the tension sensor con-
trols either the recruitment/activation of Plk1 or the accessibil-
ity of the 3F3/2 antigen on untensed kinetochores.
Figure 6. xMps1 and Plx1 are required for the assembly of the outer
kinetochore structure. (A) Nuclei were purified from mock-, xMps1-, or
xMps1-depleted extracts with the add-back of the indicated proteins, as
described in Fig. 5. Purified nuclei were stained for xNdc80 or xNuf2. (B)
Nuclei were purified from mock-, Plx1-, or Plx1-depleted extracts with the
add-back of the indicated proteins, as described in Fig. 3. Purified nuclei
were stained for xNdc80 and xNuf2. ID, immunodepletion; AB, add-
back. Bars, 5  m. 
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Another cellular response to the lack of tension is to arrest
the cell cycle progression by inhibiting APC/C (Shah and Cleve-
land, 2000). Is Plx1 involved in cell cycle arrest in 
 
X. laevis
 
checkpoint extracts? To release CSF extracts from the meiotic
metaphase II, Plx1 is required to activate APC/C through degra-
dation of xErp1, which is a checkpoint-independent inhibitor of
APC/C (Descombes and Nigg, 1998; Schmidt et al., 2005).
Thus, we were not able to directly assay the status of the check-
point arrest in Plx1-depleted extracts in the current study (un-
published data). However, the fact that Plx1 is required to target
xMad2 and xBubR1 to kinetochores supports a direct role of
Plx1 in cell cycle arrest in the extract system. Mad2 and BubR1
are two checkpoint effectors that directly bind to Cdc20 and pre-
vent premature activation of APC/C at prometaphase (Sudakin
et al., 2001; Tang et al., 2001; Fang, 2002). Both Mad2 and
BubR1 exist in two populations, kinetochore-bound forms and
cytosolic diffusive forms, and these two populations exchange
with ultrafast kinetics (Howell et al., 2000, 2004; Shah et al.,
2004). It has been proposed that the kinetochore-bound forms
receive checkpoint signals from unattached or untensed kineto-
chores, which convert them into diffusive inhibitors to inactivate
Cdc20 throughout the cytosol (Shah and Cleveland, 2000;
Musacchio and Hardwick, 2002). Indeed, cell biological analy-
ses indicate that the kinetochore-bound checkpoint proteins are
essential for checkpoint-mediated cell cycle delay (Meraldi et
al., 2004). In addition, biochemical and cell biological studies
suggest that Mad2 undergoes a conformational change mediated
through self-oligomerization at kinetochores and that this kinet-
ochore-dependent conformational change is required for inhibi-
tion of Cdc20 (Fang et al., 1998; De Antoni et al., 2005). The
lack of xMad2 and xBubR1 on kinetochores in the absence of
Plx1 indicates that Plx1 is likely required for the checkpoint ar-
rest in 
 
X. laevis
 
 extracts. This conclusion is further strengthened
by our observation that the localization of Plx1 at kinetochores is
under the control of the spindle checkpoint protein xMps1 and
that Plx1 is required for kinetochore localization of xNdc80 and
xNuf2, which form a complex required for checkpoint arrest
both in 
 
X. laevis
 
 extracts and in mammalian cells (McCleland et
al., 2003; Meraldi et al., 2004). These observations suggest that
the xMps1-dependent association of xMad2 (Abrieu et al., 2001)
and xNdc80–xNuf2 (our study) with kinetochores is likely me-
diated through the action of Plx1, and are consistent with the
previous finding that the binding of Mad2 to kinetochores de-
pends on the phosphorylation of kinetochore components in
mammalian cells (Waters et al., 1999).
We found that Plk1 is also required for phosphorylation
of the 3F3/2 epitope in human cells. A recent study, published
when the final version of the current paper was under review,
also showed that Plk1 is the 3F3/2 kinase in mammalian cells
(Ahonen et al., 2005). Thus, there may exist a common tension–
response mechanism upstream from the 3F3/2 epitope between
human and 
 
X. laevis
 
 systems. On the other hand, we noted that
our conclusions about Plx1’s role in checkpoint arrest in 
 
X. laevis
 
extracts are in sharp contrast to the mitotic function of Plk1 re-
ported in mammalian cells (for review see Barr et al., 2004).
For example, a reduction of the Plk1 level by RNAi activates,
rather than abolishes, the spindle checkpoint because of defects
in spindle assembly (Sumara et al., 2004; van Vugt et al.,
2004). In the current study, we also found that the knockdown
of Plk1 in HeLa cells activates the spindle checkpoint, even
though the levels of kinetochore-associated Mad2, but not
BubR1, are reduced, which is consistent with the findings of a
recent study (Ahonen et al., 2005). In Plk1 knockdown cells,
the 3F3/2 signals are also substantially reduced, and yet the
checkpoint arrest persists. Although a tight correlation between
the 3F3/2 epitope and the activation of the tension-sensitive
checkpoint has been observed (Gorbsky and Ricketts, 1993;
Nicklas et al., 1995, 1998), our data suggest that the 3F3/2
phosphoepitope is not required for checkpoint-mediated mi-
totic arrest, per se, in mammalian cells. In addition, the differ-
ential requirement of the Polo-like kinase in the loading of
BubR1 onto kinetochores between 
 
X. laevis
 
 extracts and hu-
man cells suggests that differences may exist in the kinetochore
assembly pathway and in the checkpoint signaling pathway be-
tween these two systems.
Alternatively, this discrepancy between the two systems
could be the result of an incomplete knockdown of Plk1 in mam-
malian cells, as has been reported for other checkpoint proteins.
For example, both xBub1 and xNdc80 are required for check-
point arrest in 
 
X. laevis
 
 extracts (Sharp-Baker and Chen, 2001;
McCleland et al., 2003). In mammalian cells, partial knockdown
of either Bub1 or Ndc80 activates the spindle assembly check-
point, whereas complete knockdown of either protein abolishes
the checkpoint (DeLuca et al., 2002; Martin-Lluesma et al.,
2002; Meraldi et al., 2004; Tang et al., 2004; Meraldi and
Sorger, 2005). Plx1 has an exceedingly high affinity to kineto-
chores, as 1% of residual Plx1 in immunodepleted 
 
X. laevis
 
 ex-
tracts was sufficient to mask the requirement of Plx1 for the
loading of xMad2, xBubR1, and xNdc80–xNuf2 onto kineto-
chores (unpublished data). The maximal degree of knockdown
we achieved in mammalian cells was 95%; therefore, it is possi-
ble that the residual Plk1 activity in mammalian knockdown
cells, although not adequate for spindle assembly, is sufficient
for checkpoint arrest. Consistent with a role of Plk1 in check-
point control in mammalian cells, it has been reported that pres-
ervation of the 3F3/2 phosphoepitope by injected 3F3/2 antibody
prolongs the checkpoint arrest and delays the onset of anaphase
during mitosis, suggesting that the 3F3/2 epitope contributes,
either directly or indirectly, to the checkpoint arrest in mamma-
lian cells (Campbell and Gorbsky, 1995). A clear causal link
between Plk1 and checkpoint arrest in mammalian cells awaits
the isolation of a potent, small molecule inhibitor of Plk1 or the
determination of the molecular identity of the 3F3/2 epitope.
What is the nature of the 3F3/2 antigen? Several candi-
dates, such as DNA topoisomerase II and subunits of APC/C
(Daum and Gorbsky, 1998; Daum et al., 2000), have been
found to contain the 3F3/2 epitope, although none has been di-
rectly linked to the tension–response pathway at kinetochores.
The demonstration that the Polo-like kinase phosphorylates the
3F3/2 epitope, a mechanism conserved both in 
 
X. laevis
 
 ex-
tracts and in human cells, provides an entry point for examin-
ing the potential function of the 3F3/2 epitope in checkpoint
control and an opportunity to investigate the molecular mecha-
nism of the tension-sensitive signaling pathway in mitosis. 
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Materials and methods
 
Recombinant proteins and antibodies
 
The following recombinant proteins were expressed and purified: His
 
6
 
-
xMad1 (aa 321–562), His
 
6-xMad2, GST-xBub1 (aa 1–670), GST-xBubR1
(aa 1–197), GST-xMps1 (kinase-dead mutant), and His6-Plx1 (aa 225–
598). All recombinant proteins were expressed in Escherichia coli, except
xMps1, which was expressed in Sf9 cells. Rabbit antibodies were raised
against the aforementioned recombinant proteins and affinity purified. An-
tisera against Plx1 were provided by R. Heald (University of California,
Berkeley, Berkeley, CA). Anti-Ndc80 and -Nuf2 antibodies were provided
by T. Stukenberg (University of Virginia, Charlottesville, VA), and anti-
Cenp-A antibody was provided by A. Straight (Stanford University, Stan-
ford, CA). Rabbit antibodies against human Mad2 and BubR1 were de-
scribed previously (Fang, 2002). Commercial antibodies were obtained
as follows: 3F3/2 ascite from Boston Biologicals, mAb and rabbit anti-
body against Plk1 (for immunofluorescence in HeLa cells) from Santa Cruz
Biotechnology, Inc., monoclonal Plk1 antibody (for Western blotting) from
Zymed Laboratories, and Crest serum from Antibodies, Inc.
GST-xAurora B was expressed in E. coli and purified with glu-
tathione-Sepharose beads. The recombinant xAurora B was tested for its
ability to phosphorylate Histone H3 and was found to be highly active, al-
though it is possible that the kinase by itself is not able to recognize all the
physiological substrates in the absence of INCENP and Survivin. Active
Cdc2/cyclin B kinase was purchased from New England Biolabs, Inc. Re-
combinant Plx1 protein was provided by P. Jackson (Stanford University,
Stanford, CA).
Preparation of X. laevis egg extracts, immunodepletion, and translation in 
extracts
Meiotic metaphase extracts (CSF extracts) from X. laevis eggs and demem-
branated sperm nuclei were prepared as described previously (Minshull et
al., 1994).
For immunodepletion, 75  g of affinity-purified antibodies were
coupled to 8  l of Affi-prep protein A beads (Bio-Rad Laboratories) by
dimethyl pimelimidate (Pierce Chemical Co.). The antibody beads were
then incubated with 50  l of CSF extracts for 1 h at 4 C and pelleted at
4 C. The depletion conditions were as follow: one round of immunodeple-
tion for xMps1, two successive rounds for xBub1 and xBubR1, and three
successive rounds for Plx1. To achieve reproducible high-depletion effi-
ciency of Plx1 ( 99.5%), anti-Plx1 antibodies were not cross-linked to the
protein A beads, as cross-linking reduced the depletion efficiency.
For in vitro translation in extracts, mRNAs were transcribed from lin-
earized plasmids encoding xMps1 and Plx1 using mMessage mMachine
transcription kit (Ambion). Translation reactions were performed in CSF
extracts that had been depleted of the protein of interest. Proteins trans-
lated in depleted extracts were used in rescue experiments. xMps1 con-
struct was provided by D. Cleveland (University of California, San Diego,
San Diego, CA), Plx1 by J. Maller (University of Colorado, Denver, CO),
and xBub1 by R.H. Chen (Cornell University, Ithaca, NY). The kinase-
dead mutants of xMps1 and Plx1 used in this paper were xMps1 D685A
and Plx1 N172A (Qian et al., 1998; Abrieu et al., 2001).
Spindle checkpoint extracts were prepared as described previously
(Minshull et al., 1994) with the following modifications: CSF extracts
(fresh or depleted of the protein of interest) were incubated with demem-
branated sperm nuclei and nocodazole. For rescue experiments, in vitro–
translated proteins were added to depleted extracts and incubated for
10 min at RT before the addition of sperm nuclei and nocodazole.
Immunofluorescence microscopy
Spindle checkpoint extracts were fixed in fixation buffer (80 mM Pipes,
pH 6.8, 2 mM MgCl2, 1 mM EGTA, 30% glycerol, 0.5% Triton X-100,
0.5  M microcystin-LR, and 2% formaldehyde). Each sample was then lay-
ered onto a centrifuge tube filled with CSF-XB (10 mM Hepes, pH 7.8, 50
mM sucrose, 100 mM KCl, 2 mM MgCl2, and 1 mM EGTA) plus 0.5% Tri-
ton X-100 and 40% glycerol. A poly-L-lysine–coated coverslip was placed
at the bottom of each tube, and nuclei were spun onto the coverslip. Cov-
erslips were recovered, fixed with 2% formaldehyde in CSF-XBT (CSF-XB
with 0.1% Triton X-100), blocked by CSF-XBT plus 3% BSA, and incu-
bated with primary and secondary antibodies (Molecular Probes). Images
were captured on a microscope (Axiovert 200M; Carl Zeiss MicroImag-
ing, Inc.) equipped with a 100  1.4 NA lens, a digital charge-coupled
device camera (Hamamatsu Photonics), and Openlab 4.0.2 (Improvision).
For quantitative comparison of fluorescence intensities (Figs. 2 E, 3 C, and
4 C), antibody concentrations were titrated to ensure a linear response of
immunofluorescence signals to the antigen concentrations, and images
were taken with identical exposure time and processed identically. The
mean fluorescence intensity values and their standard deviations were cal-
culated from  15 kinetochores taken from multiple nuclei.
XTC cells were grown at RT on poly-L-lysine–coated coverslips in L-15
medium supplemented with 10% FBS and 1% penicillin-streptomycin.
HeLa cells were grown in DME supplemented with 10% FBS and 1%
penicillin-streptomycin. Samples were fixed with 0.1% PFA in CSF-XB plus
0.5  M of microcystin LR, permeabilized in CSF-XB plus 0.5% Triton X-100
and 0.5  M of microcystin LR, and incubated in CSF-XBT and 0.5  M of
microcystin LR. Subsequently, the samples were fixed again with 2% PFA
in CSF-XBT plus 0.5  M of microcystin LR, and then blocked in CSF-XBT
plus 3% egg albumin before being processed for immunofluorescence
staining. For taxol-treated samples, cells were grown in the presence of
100 nM taxol for 15 h and then fixed immediately or released into fresh
medium for 15 min before fixing.
Dephosphorylation and rephosphorylation reactions
Nuclei were purified onto coverslips from spindle checkpoint extracts. To
remove the 3F3/2 phosphoepitope, coverslips were incubated with  -phos-
phatase (New England Biolabs, Inc.) at 2 U/ l for 15 min.
For rephosphorylation in Fig. 1 D, coverslips were treated with the
phosphatase and rinsed twice with RPB (50 mM Tris-HCl, pH 7.7, 5 mM
MgCl2, and 1  M of microcystin LR), and phosphorylation reaction was
done in RPB plus 2 mM ATP. Coverslips were then processed for immuno-
fluorescence staining.
For all other rephosphorylation reactions, coverslips were incu-
bated with phosphatase and then with 5 mM NEM (Sigma-Aldrich) in 50
mM Tris-HCl, pH 7.7, and 5 mM MgCl2 to inactivate endogenous kinases.
The reaction was quenched by 1 mM DTT in CSF-XBT and blocked in CSF-
XBT plus 3% BSA, 0.5  M of microcystin LR, and 1 mM DTT. For rephos-
phorylation with extracts, coverslips were incubated, in the presence of
2 mM ATP, 1 mM DTT, and 1  M of microcystin LR, with 35  l of CSF ex-
tracts either mock depleted or depleted of an endogenous kinase (xMps1,
xBub1, xBubR1, or Plx1). For rephosphorylation with recombinant kinase,
coverslips were incubated with 0.5  g His6-Plx1 in 40  l RPB plus 2 mM
ATP and 1 mM DTT. Coverslips were then processed for immunofluores-
cence staining.
Knockdown of Plk1 in HeLa cells
HeLa cells were grown on coverslips and synchronized by double-thymi-
dine arrest and release (Fig. 4 A). SmartPool siRNAs against Plk1 (Dhar-
macon, Inc.) were transfected 3 h before the second thymidine arrest by a
DF1 reagent (Dharmacon, Inc.), and the transfection mix was present
throughout the second thymidine arrest. Cells were fixed and assayed by
immunofluorescence staining 11 to 14 h after release from the second
thymidine arrest.
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